There is little information concerning the long term outcome of patients with gastrooesophageal reflux disease (GORD). Thus 109 patients with reflux symptoms (33 with erosive oesophagitis) with a diagnosis of GORD after clinical evaluation and oesophageal testing were studied. AU patients were treated with a stepwise approach: (a) lifestyle changes were suggested aimed at reducing reflux and antacids and the prokinetic agent domperidone were prescribed; (b) H2 blockers were added after two months when symptoms persisted; (c) anti-reflux surgery was indicated when there was no response to (b). Treatment was adjusted to maintain clinical remission during follow up. Long term treatment need was defined as minor when conservative measures sufficed for proper control, and as major if daily H2 blockers or surgery were required. The results showed that one third of the patients each had initial therapeutic need (a), (b), and (c). Of 103 patients available for follow up at three years and 89 at six years, respective therapeutic needs were minor in 52% and 55% and major in 48% and 45%. Eighty per cent of patients in (a), 67% in (b), and 17% in (c) required only conservative measures at six years. A decreasing lower oesophageal sphincter pressure (p<0-001), radiological reflux (p=0028), and erosive oesophagitis (p=0-031), but not initial clinical scores, were independent predictors of major therapeutic need as shown by multivariate analysis. The long term outcome of GORD is better than previously perceived.
Abstract
There is little information concerning the long term outcome of patients with gastrooesophageal reflux disease (GORD). Thus 109 patients with reflux symptoms (33 with erosive oesophagitis) with a diagnosis of GORD after clinical evaluation and oesophageal testing were studied. AU patients were treated with a stepwise approach: (a) lifestyle changes were suggested aimed at reducing reflux and antacids and the prokinetic agent domperidone were prescribed; (b) H2 blockers were added after two months when symptoms persisted; (c) anti-reflux surgery was indicated when there was no response to (b) . Treatment was adjusted to maintain clinical remission during follow up. Long term treatment need was defined as minor when conservative measures sufficed for proper control, and as major if daily H2 blockers or surgery were required. The results showed that one third of the patients each had initial therapeutic need (a), (b), and (c). Of 103 patients available for follow up at three years and 89 at six years, respective therapeutic needs were minor in 52% and 55% and major in 48% and 45%. Eighty per cent of patients in (a), 67% in (b), and 17% in (c) required only conservative measures at six years. A decreasing lower oesophageal sphincter pressure (p<0-001), radiological reflux (p=0028), and erosive oesophagitis (p=0-031), but not initial clinical scores, were independent predictors of major therapeutic need as shown by multivariate analysis. The long term outcome of GORD is better than previously perceived. (Gut 1994; 35: 8-14) Gastro-oesophageal reflux disease (GORD) is a common ailment. A cross sectional survey of presumably healthy people in the United States has found that 10% experience heartburn daily and up to 40% have it at least once a month.' Indeed, most otherwise healthy heavy consumers of antacids have reflux disease. 2 Gastro-esophageal reflux disease is a chronic disease that requires long term management in nearly all patients. The conventional medical treatment begins with modifications of lifestyle that are aimed at reducing the reflux of gastric contents into the oesophagus, such as dietary, alcohol, drug, and tobacco restriction, and elevation of the bedhead; such measures, together with appropriate antacid use, are usually effective for patients with clinically mild GORD, whereas patients with more frequent or severe reflux symptoms often require some form of acid suppressive medication with or without addition of gastric prokinetic agents.3 Antireflux surgery is a good alternative treatment for patients who do not respond well to medical treatment. 4 About one third of the patients with heartburn who seek medical care have endoscopic evidence of oesophagitis,' and therapeutic studies of GORD have been limited primarily to short term observations of the effects of single drugs in this subset of patients, with little or no emphasis on modifications of lifestyle.6 Recent clinical trials in patients with oesophagitis suggest that most patients relapse quickly when treatment is interrupted after healing7-'0; however, a bias toward more severe cases to enter such trials cannot be discounted. There is little information about the long term clinical course of patients with peptic oesophagitis after diagnosis," and even less on patients with GORD but no oesophagitis.
The present study was carried out in a consecutive series of outpatients referred to a gastroenterology clinic who sought medical care because of reflux symptoms and had confirmed GORD, with and without oesophagitis. The patients were submitted initially to a stepwise therapeutic regimen until clinical remission and were subsequently given maintenance treatment sufficient for them to feel satisfied. They were then followed up for up to six years. Our aims were to devise a rational therapeutic approach to GORD and to assess the existence of predictive factors of the long term outcome. The information gathered in the study provides a comprehensive evaluation of the efficacy of prolonged treatment in GORD. Manometry to determine mean basal lower oesophageal sphincter pressure (LOSP) and peristaltic response to wet swallows were performed as described.'5 A standard acid reflux test'6 without HC1 loading was carried out at the end of the oesophageal motility study. In January 1984 this test was substituted by stationary 24 hour oesophageal pH monitoring, which was performed and interpreted as previously reported. '7 The diagnosis of GORD was based on a positive result in at least two of the following tests: spontaneous reflux of barium during radiological studies, erosions or ulcerations of the oesophageal mucosa at endoscopy, microscopic oesophagitis on endoscopic biopsy specimens, LOSP s,7 mm Hg (mean -2 SD of our motility laboratory controls),'5 pH <4 during a standard acid reflux test or abnormal reflux by 24 h pH monitoring.
Patients and methods

PATIENTS
Because all patients completing the long term study had a follow up of at least six years, outcomes were evaluated at three and six years after entry. Six possible outcomes were defined: (1) no symptoms or occasional symptoms requiring antacids; (2) sustained remission with frequent consumption of antacids with or without domperidone alone; (3) seasonal symptoms requiring full courses of treatment with either antacids or H2 blockers, with intervening periods as in outcomes 1 or 2; (4) sustained remission with daily maintenance doses of H2 blockers; (5) need of uninterrupted treatment with full dose H2 blockers; (6) anti-reflux procedure performed. To simplify the expression of results, outcomes 1 to 3 were grouped together as 'minor therapeutic need' (patients were comfortable most of the time utilising simple, inexpen- Long term outcome Whereas two thirds of the patients had initially required H2 blockers, 52% and 55% of those available for follow up at three and six years, respectively, fared well with a conservative approach (Table III) . Anti-reflux surgery resulted in long lasting remission ofreflux symptoms in 22 of 23 patients who were operated on and who have been followed up for 72 (15) , range 54-1 16 months. Table IV shows the treatment needs during long term follow up in relation to the outcome of initial, graded treatment. Nearly all patients who had a good initial response to domperidone plus antacids were well controlled with conservative measures at three and six years, and the same applied to nearly two thirds of those who had required H2 blockers at the outset. tRequiring uninterrupted treatment with H2 blockers at either maintenance or stepped up doses. tNo further patients underwent anti-reflux surgery after three years and none was lost from follow up.
u. The relation of initial oesophagitis grade and basal LOSP with three year therapeutic need for each patient (Figure) shows that both oesophagitis and low LOSP (Table  VI ) also shows that oesophagitis and low LOSP, in addition to radiological reflux, were associated with major therapeutic need.
By multivariate analysis, the following factors were shown to be independent predictors of vigorous treatment requirements: low LOSP (p<0-001), radiological reflux (p=0-028), and erosive oesophagitis (p=0-031). Respective positive predictive values, derived from data in Table V and the Figure, 
Discussion
In this study 107 consecutive outpatients with documented GORD were prospectively evaluated with a clinical score, radiology, endoscopy, and manometry. They were subsequently managed with lifestyle changes plus a stepwise therapeutic approach and followed up for up to six years. Patient's satisfaction was the main factor that influenced treatment adjustments; thus the success of treatment (symptomatic remission) was determined by the patients rather than by their physicians. The results show that a conservative approach can provide long lasting remission in many patients and suggest that, once those with worse GORD are treated with anti-reflux surgery, the disease tends to run a 17 10 Quit smoking (No (%)) 9 (53) 1 (10) Obese (No) 17 18
Lost >5 kg (No (%)) (table IV) , the initial response to graded treatment was a good predictor of treatment needs during long term follow up only for patients achieving symptomatic remission with conservative treatment.
Thus 80% of those and 67% of patients initially requiring H2 blockers had a lasting response to simple modes of treatment, which was shared by 17% of the patients who had been refractory to short term medical management but did not have anti-reflux surgery. The results challenge the presumption that long term intensive treatment is necessary for most patients with GORD. Other authors7-'0 have reported that patients with oesophagitis relapse quickly when pharmacological treatment is interrupted. Both selection of more severe cases and the overlooking of lifestyle modifications in these studies7'-0 could explain the differences from our present series.
At all times during prolonged patient care in our study emphasis was placed on simplistic, traditional modes of treatment, such as diet modification, elevation of the bedhead, tobacco, alcohol and drug restriction, and antacid use. As recently reviewed,30 these measures are based on sound physiological principles but are often neglected in this age of potent acid suppressive drugs. In our study controllable changes, like stopping smoking and weight loss, occurred more often in patients who did well on conservative treatment (Table VI) .
Little is known about factors influencing therapeutic responses in GORD.729 We did not carry out tests for alkaline reflux, which can be associated with complications of oesophagitis or refractoriness to medical treatment.3' The logistic regression analysis in our study shows that a low basal LOSP, the detection of reflux by barium meal, and the existence of oesophageal erosions as judged by endoscopy, independently predict the long term need for sustained pharmacological acid suppression or anti-reflux surgery in GORD. According to their positive predictive values, the presence of each one of these variables would correctly predict the long term course in roughly two out ofevery three patients, thus their investigation should be clinically useful. The association of low LOSP with vigorous long term treatment requirements is consistent with available evidence." 21 27 3233 A potential explanation for the fact that radiological reflux had prognostic value independently of LOSP could be that, as well as a low basal LOSP, it reflected an increased rate of transient relaxations of a normotensive lower oesophageal sphincter after the barium meal.4 As expected,729 another independent predictor of need for continuous treatment was the presence of endoscopic oesophagitis at initial evaluation. Taken together, these results suggest that refractoriness to conservative treatment in GORD is due to the severity of the reflux itself.
For such a common disease as GORD, it is surprising how little is known about the long term outcome of treated patients. Studies of patients with oesophagitis followed up for periods of two to three years under continuous treatment with antacids32 or H2 blockers with or without added metoclopramide" indicate that a significant proportion of patients have frequent symptomatic relapses when treatment is tapered off. On the other hand, continuous treatment of patients with complicated GORD with a combination of general anti-reflux measures, antacids, and standard doses of ranitidine is useful in controlling symptoms for up to two years, although surgical treatment is more effective.35 A recent study suggests that most patients with non-erosive GORD treated with antacids, but not advised on lifestyle changes, have persisting symptoms after one year.36 Schindlbeck et al37 have recently reported that less than a quarter of patients with conventional GORD treated conservatively improve after three years; these patients, however, were not directly followed up by the authors after diagnosis, and no mention is made of modifications in lifestyle.37 A different picture emerges from our study, which shows that more than half of unselected patients with GORD do well with simple modes of treatment for up to six years. Consequently, the clinical course of GORD under continuous medical surveillance seems to be more benign than previously presumed.
The clinical experience gained in this study supports the notion that conservative treatment should be tried initially in patients with reflux symptoms.32' 30 Many patients will be expected to have a lasting response to this simple, low cost approach. In non-responding patients, radiological, endoscopic, and manometric findings have predictive value for the long term outcome and can help in the early selection of candidates for anti-reflux surgery or, alternatively, sustained pharmacological acid suppression.
